Blog
RSS FeedPosted by Michael Wonder on 10 Jul 2020
Proposal to modify PHARMAC’s approach to competitive procurement
10 July 2020 - PHARMAC is proposing to standardise the way that it contracts for pharmaceuticals as a result of ...
Posted by Michael Wonder on 02 Jul 2020
Modifying funded access to mifepristone and misoprostol
2 July 2020 - PHARMAC is pleased to announce a decision to: ...
Posted by Michael Wonder on 30 Jun 2020
After years of feuds, Vertex and the U.K. government reach a deal over cystic fibrosis medicines
30 June 2020 - U.K. officials and Vertex Pharmaceuticals have finally put to rest a years-long battle over access to ...
Posted by Michael Wonder on 30 Jun 2020
Funding applications declined
30 June 2020 - Another lame response from PHARMAC. ...
Posted by Michael Wonder on 18 Jun 2020
UK launches world's first ‘subscription-style’ payment model for antibiotics
18 June 2020 - A government scheme to fuel the development of new antibiotics by offering to pay pharmaceutical companies ...
Posted by Michael Wonder on 17 Jun 2020
Delay in decision on modifying funded access to mifepristone and misoprostol proposal
17 June 2020 - PHARMAC would like to advise all interested parties that there will be a delay in the decision ...
Posted by Michael Wonder on 16 Jun 2020
Additional $92 million, or 5 percent, government funding for pharmaceutical wholesalers
16 June 2020 - Pharmaceutical wholesalers will receive an additional $92 million, or 5 per cent, funding from the federal ...
Posted by Michael Wonder on 20 May 2020
Atomoxetine – further delay in change of funded brand and open access
20 May 2020 - PHARMAC is advising all interested parties that there is a further one-month delay in the listing ...
Posted by Michael Wonder on 12 May 2020
Racing getting more from budget than PHARMAC
12 May 2020 - It is a damning indictment of the Government’s priorities that the racing industry is getting more ...
Posted by Michael Wonder on 12 May 2020
Decision to fund pancreatic enzymes modified-release granules (Creon Micro)
12 May 2020 - PHARMAC is pleased to announce a decision to fund pancreatic enzymes modified-release granules (Creon Micro) from ...
Posted by Michael Wonder on 11 May 2020
PHARMAC funding increase "extremely disappointing"
11 May 2020 - Rare Disorders NZ is extremely disappointed with the announcement yesterday of a pre-budget boost to PHARMAC’s funding ...
Posted by Michael Wonder on 11 May 2020
Lung cancer victims miss out in drug funding boost - advocates
11 May 2020 - Advocates for lung cancer sufferers say the extra funding for PHARMAC in this year's Budget won't help ...
Posted by Michael Wonder on 11 May 2020
New Zealand’s medicines system still on life-support but can be saved
11 May 2020 - Medicines New Zealand welcomes the Government’s announcement of new investment in the medicines budget as any ...
Posted by Michael Wonder on 11 May 2020
PHARMAC drugs stretching Southern DHB budget
11 May 2020 - PHARMACs approval of life-extending drugs is putting significant strain on the Southern District Health Board's budget, ...
Posted by Michael Wonder on 10 May 2020
“Don’t back away from cancer drug plan,” Breast Cancer Foundation begs
10 May 2020 - “Don’t use COVID-19 as an excuse to back away from your commitment to cancer patients,” Breast ...